
Even if they leave average cost the same, interventions that decrease cost variability have economic value.
Even if they leave average cost the same, interventions that decrease cost variability have economic value.
Many large, well-integrated medical groups with infrastructure to manage care effectively continue to receive a majority of revenue from fee-for-service and pay physicians based on productivity.
By using a novel, pre-defined advance care planning (ACP) framework, the personal health record can be used to elicit meaningful ACP documentation that is effective for both patients and providers.
An analysis of claims from over 90,000 patients with type 2 diabetes (T2D) demonstrates that increased medication cost sharing is associated with higher rates of hospitalization and increased plan costs.
Health plans with tiered physician networks channel patients associated with the highest proportion of medical spending to higher value providers.
After Medicaid expansion in Michigan, appointment availability for new Medicaid patients stably increased-this is perhaps attributable to increasing proportions of appointments scheduled with nonphysician providers.
The Medicare program’s transition in 2004 to tiered fee-for-service physician reimbursement for dialysis care had the unintended consequence of reducing use of home dialysis.
New hepatitis C medications have been quickly adopted into practice and increased treatment rate. The median out-of-pocket costs of new medications were relatively low.
Reducing lipid levels in high-risk patients can significantly reduce disease burden and, depending on final negotiated prices, PCSK9 inhibitors can make an economic contribution to this goal.
This literature review evaluates the impact of restricted access to atypical antipsychotic drugs in individuals with schizophrenia or bipolar disorder.
Large-scale analysis of Harvard Business School’s physician graduates yields new insights into physician-MBA career choices and the utility of these programs.
This article explores the role of subspecialists in new care delivery models and argues compensation should recognize the range of ways subspecialists provide value to populations.
259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.